Ridgewood Investments’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
Ridgewood Investments's CLB Position: Q3 2025 in Review
Ridgewood Investments reduced its Core Laboratories (CLB) stake by 6.1% in Q3 2025, selling an estimated $24.1K and leaving 31,434 shares worth $389K. The position accounts for 0.16% of the portfolio, ranked #153.
Ridgewood Investments first reported a position in CLB in Q4 2016 and has held it in 28 quarters since. The position peaked at $669K in Q1 2023. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.
- Ridgewood Investments held 31,434 shares of Core Laboratories worth $389K as of Q3 2025.
- Ridgewood Investments sold 2,055 Core Laboratories shares in Q3 2025, an estimated $24.1K.
- Core Laboratories made up 0.16% of Ridgewood Investments's portfolio in Q3 2025, its #153 holding.
- Ridgewood Investments first reported a position in Core Laboratories in Q4 2016 and has held it in 28 quarters since.
- Ridgewood Investments's Core Laboratories position peaked at $669K in Q1 2023.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.
Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.